Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials

JAMA

Volumn 309, Issue 1, 2013, Pages 55-62

  Al Khatib, Sana M ^a,b   Hellkamp, Anne ^a   Bardy, Gust H ^c   Hammill, Stephen ^d   Hall, W Jackson ^e   Mark, Daniel B ^a,b   Anstrom, Kevin J ^a   Curtis, Jeptha ^f   Al Khalidi, Hussein ^a   Curtis, Lesley H ^a,b   Heidenreich, Paul ^g   Peterson, Eric D ^a,b   Sanders, Gillian ^a   Clapp Channing, Nancy ^a   Lee, Kerry L ^a   Moss, Arthur J ^e  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; UREA;

ADULT; AGE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY (TOPIC); PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

EID: 84871760307     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.157182     Document Type: Article

References (18)

1. Moss AJ, Hall WJ, Cannom DS, et al; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26):1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341(25):1882-1890.
3. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883.
4. Bardy GH, Lee KL, Mark DB, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237.
5. Cardinal H, Monfared AA, Dorais M, LeLorier J. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue. Can J Cardiol. 2004;20(4):417-421.
6. Pedone C, Lapane KL. Generalizability of guidelines and physicians' adherence: case study on the Sixth Joint National Committee's guidelines on hypertension. BMC Public Health. 2003;3:24.
7. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry. 2003;64(9):1091-1093.
8. Bahit MC, Cannon CP, Antman EM, et al; TIMI 9 Trial and TIMI 9 Registry. Thrombolysis In Myocardial Infarction. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003;145(1):109-117.
9. Walsh CR, Lloyd-Jones DM, Camargo CA Jr, Giugliano RP, O'Donnell CJ. Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients? Am J Cardiol. 2000;86(9):908-912.
10. Hordijk-Trion M, Lenzen M, Wijns W, et al; EHS-CR Investigators. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J. 2006;27(6):671-678.
11. Badano LP, Di Lenarda A, Bellotti P, Albanese MC, Sinagra G, Fioretti PM. Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials. Ital Heart J. 2003;4(2):84-91.
12. The ICD Registry Program. Heart Rhythm Society. http://www.hrsonline.org/ Practice-Guidance/Quality-Outcomes-Reporting/ICD-Registry. Accessed December 11, 2012.
13. ICD Registry. National Cardiovascular Data Registry. http://www.ncdr.com/ webncdr/ICD/Default.aspx. Accessed August 15, 2010.
14. Hammill SC, Kremers MS, Kadish AH, et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009;6(9):1397-1401.
15. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1):33-38.
16. Al-Khatib SM, Mi X, Qualls L, et al. Follow-up of patients with new cardiovascular implantable electronic devices: are the experts' recommendations being implemented in routine clinical practice? [abstract]. Heart Rhythm. 2012;9(5 suppl):S381.
17. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol. 2005;46(8):1536-1540.
18. Hernandez AF, Fonarow GC, Hammill BG, et al. Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3(1):7-13.